IDEAYA Biosciences, Inc. (IDYA)
31.67
-0.16
(-0.50%)
USD |
NASDAQ |
Apr 22, 16:00
31.65
-0.02
(-0.06%)
Pre-Market: 08:38
IDEAYA Biosciences EPS Diluted (Quarterly) : -0.9401 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Amgen, Inc. | 2.455 |
| Spyre Therapeutics, Inc. | -0.6903 |
| Replimune Group, Inc. | -0.7694 |
| Black Diamond Therapeutics, Inc. | -0.2648 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -83.27M |
| Revenue (Quarterly) | 10.88M |
| Total Expenses (Quarterly) | 94.15M |
| Enterprise Value | 2.170B |
| Gross Profit Margin (Quarterly) | 88.99% |
| Profit Margin (Quarterly) | -765.7% |
| Earnings Yield | -4.12% |
| Normalized Earnings Yield | -4.115 |